1. Home
  2. VCIG vs PLRZ Comparison

VCIG vs PLRZ Comparison

Compare VCIG & PLRZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VCIG
  • PLRZ
  • Stock Information
  • Founded
  • VCIG 2013
  • PLRZ 2005
  • Country
  • VCIG Malaysia
  • PLRZ Israel
  • Employees
  • VCIG N/A
  • PLRZ N/A
  • Industry
  • VCIG Diversified Commercial Services
  • PLRZ
  • Sector
  • VCIG Consumer Discretionary
  • PLRZ
  • Exchange
  • VCIG Nasdaq
  • PLRZ NYSE
  • Market Cap
  • VCIG 5.8M
  • PLRZ 5.9M
  • IPO Year
  • VCIG 2023
  • PLRZ 2024
  • Fundamental
  • Price
  • VCIG $1.30
  • PLRZ $1.54
  • Analyst Decision
  • VCIG
  • PLRZ
  • Analyst Count
  • VCIG 0
  • PLRZ 0
  • Target Price
  • VCIG N/A
  • PLRZ N/A
  • AVG Volume (30 Days)
  • VCIG 2.0M
  • PLRZ 8.2M
  • Earning Date
  • VCIG 01-28-2025
  • PLRZ 02-15-2025
  • Dividend Yield
  • VCIG 37.69%
  • PLRZ N/A
  • EPS Growth
  • VCIG N/A
  • PLRZ N/A
  • EPS
  • VCIG 7.82
  • PLRZ N/A
  • Revenue
  • VCIG $23,548,256.00
  • PLRZ N/A
  • Revenue This Year
  • VCIG N/A
  • PLRZ N/A
  • Revenue Next Year
  • VCIG N/A
  • PLRZ N/A
  • P/E Ratio
  • VCIG $0.17
  • PLRZ N/A
  • Revenue Growth
  • VCIG 89.38
  • PLRZ N/A
  • 52 Week Low
  • VCIG $1.25
  • PLRZ $0.77
  • 52 Week High
  • VCIG $103.39
  • PLRZ $4.80
  • Technical
  • Relative Strength Index (RSI)
  • VCIG 37.14
  • PLRZ N/A
  • Support Level
  • VCIG $1.68
  • PLRZ N/A
  • Resistance Level
  • VCIG $2.15
  • PLRZ N/A
  • Average True Range (ATR)
  • VCIG 0.25
  • PLRZ 0.00
  • MACD
  • VCIG -0.00
  • PLRZ 0.00
  • Stochastic Oscillator
  • VCIG 5.56
  • PLRZ 0.00

About VCIG VCI Global Limited

VCI Global Ltd is a holding company. The principal activities of the Company and its subsidiaries are the provision of business Strategy consultancy and technology development solution consultancy. The firm organized its consulting services into three main segments: Business Strategy Consultancy; Technology Consultancy; and Others. It derives the majority of its revenue from the Business Strategy Consultancy segment which focuses on listing solutions, investor relations, and boardroom strategies consultancy. It has established a diverse local and international clientele, providing them with its services in both local and cross-border listings. Its role begins with pre-listing diagnosis and planning to the finalization of the entire listing process.

About PLRZ POLYRIZON LTD

Polyrizon Ltd is a clinical development stage biotech company specializing in the development of nasal gels to provide preventative treatment to protect against a wide cross-section of viruses, including certain variants of COVID-19 that are also considered to cause more infections and spread faster than the original strain of the virus (the CDC expects that additional variants of the virus will continue to occur), influenza, allergens, and other toxins. Its technology platforms are Capture & Contain and Trap & Target.

Share on Social Networks: